glp-1 concentration Plasma concentrations of GIP (a), (b) and glucose (c), and glp 1 receptor concentration estimate

Usage and visibility of GLP-1s have been increasing, especially among younger generations

found that exendin-4 could reduce the resistance of prostate cancer cells to enzalutamide by targeting the PI3K/AKT/mTOR pathway, while combined use of exendin-4 and enzalutamide could significantly inhibit the growth of prostate cancer cells (210)

If we look at the numbers, the trajectory of GLP-1 (glucagon-like peptide-1) receptor agonists is not just a growth story

Market sizing for these expanded indications has been substantial [18, 29], yielding a very high velocity assessment

This article reviews the current research progress on the antitumor effects of TCMs through the induction of ferroptosis